F2 and Cirrhosis: However, it must be noted, that prothrombin time and INR are no longer accepted as means of determining thrombotic or bleeding risk in patients with cirrhosis (45), as these tests only measure the levels of procoagulant proteins and fail to account for the concurrent alterations in anticoagulant proteins or platelets that are known to occur in those patients (46).